Search

Displaying results 7591 - 7600 of 10000 in total
  1. Drug

    Selitrectinib

    go.drugbank.com/drugs/DB14896
    Investigational

    Selitrectinib is under investigation in clinical trial NCT03215511 (Phase 1/2 Study of LOXO-195 in Patients With Previously Treated NTRK Fusion Cancers).

  2. Drug

    5-methyl-2'-fluoroarauracil F-18

    go.drugbank.com/drugs/DB14913
    Investigational

    5-methyl-2'-fluoroarauracil F-18 is under investigation in clinical trial NCT02809690 (18F-FMAU PET/CT in Diagnosing and Characterizing Prostate Cancer).

  3. Drug

    BMS-929075

    go.drugbank.com/drugs/DB14950
    Investigational

    BMS-929075 is under investigation in clinical trial NCT01525212 (Multiple Ascending Dose Study of BMS-929075 in Hepatitis C Virus (HCV) Infected Patients).

  4. Drug

    Opicinumab

    go.drugbank.com/drugs/DB14959
    Investigational

    Opicinumab is under investigation in clinical trial NCT02641041 (Safety, Tolerability, and Pharmacokinetics of Single and Multiple Doses of BIIB033 in Healthy Japanese Participants).

  5. Drug

    AOC 1001

    go.drugbank.com/drugs/DB18620
    Investigational

    Delpacibart (AOC 1001) is being investigated in a global study for the treatment of Myotonic Dystrophy type 1 (DM1) in clinical trial NCT06411288

  6. Drug

    Bafisontamab

    go.drugbank.com/drugs/DB16091
    Investigational

    EMB-01 is under investigation in clinical trial NCT03797391 (A Dose Escalation Study of EMB-01 in Participants With Advanced/metastatic Solid Tumors).

  7. Drug

    Selgantolimod

    go.drugbank.com/drugs/DB16324
    Investigational

    Selgantolimod is under investigation in clinical trial NCT03491553 (Safety, Tolerability and Antiviral Activity of Selgantolimod in Virally-suppressed Adults With Chronic Hepatitis B).

  8. Drug

    Taniborbactam

    go.drugbank.com/drugs/DB16338
    Investigational

    Taniborbactam is under investigation in clinical trial NCT03840148 (Safety and Efficacy Study of Cefepime/vnrx-5133 in Patients With Complicated Urinary Tract Infections).

  9. Drug

    Bexmarilimab

    go.drugbank.com/drugs/DB16383
    Investigational

    Bexmarilimab is under investigation in clinical trial NCT03733990 (A Study to Evaluate Safety, Tolerability and Preliminary Efficacy of FP-1305 in Cancer Patients).

  10. Drug

    Camoteskimab

    go.drugbank.com/drugs/DB18876
    Investigational

    Camoteskimab is under investigation in clinical trial NCT06436183 (A Study of the Effects of Camoteskimab in Adults With Moderate to Severe Atopic Dermatitis).